Next Article in Journal
Anti-Diabetic and Hepato-Renal Protective Effects of Ziyuglycoside II Methyl Ester in Type 2 Diabetic Mice
Next Article in Special Issue
Postprandial Differences in the Amino Acid and Biogenic Amines Profiles of Impaired Fasting Glucose Individuals after Intake of Highland Barley
Previous Article in Journal
Modifying Choroidal Neovascularization Development with a Nutritional Supplement in Mice
Previous Article in Special Issue
NO-Rich Diet for Lifestyle-Related Diseases
Article Menu

Export Article

Open AccessReview
Nutrients 2015, 7(7), 5443-5468; doi:10.3390/nu7075230

Epigallocatechin Gallate: A Review of Its Beneficial Properties to Prevent Metabolic Syndrome

1
INSERM U1063, Stress oxydant et pathologies métaboliques, LUNAM Université, Angers 49045, France
2
UFR des Sciences Pharmaceutiques et Ingénierie de la Santé, Département pharmacie, Laboratoire de pharmacologie, LUNAM Université, Angers 49045, France
These authors contributed equally to this work.
*
Author to whom correspondence should be addressed.
Received: 22 May 2015 / Revised: 25 June 2015 / Accepted: 30 June 2015 / Published: 7 July 2015
(This article belongs to the Special Issue Diet and Metabolic Dysfunction)
View Full-Text   |   Download PDF [329 KB, uploaded 7 July 2015]   |  

Abstract

Obesity and being overweight are linked with a cluster of metabolic and vascular disorders that have been termed the metabolic syndrome. This syndrome promotes the incidence of cardiovascular diseases that are an important public health problem because they represent a major cause of death worldwide. Whereas there is not a universally-accepted set of diagnostic criteria, most expert groups agree that this syndrome is defined by an endothelial dysfunction, an impaired insulin sensitivity and hyperglycemia, dyslipidemia, abdominal obesity and hypertension. Epidemiological studies suggest that the beneficial cardiovascular health effects of diets rich in green tea are, in part, mediated by their flavonoid content, with particular benefits provided by members of this family such as epigallocatechin gallate (EGCG). Although their bioavailability is discussed, various studies suggest that EGCG modulates cellular and molecular mechanisms of various symptoms leading to metabolic syndrome. Therefore, according to in vitro and in vivo model data, this review attempts to increase our understanding about the beneficial properties of EGCG to prevent metabolic syndrome. View Full-Text
Keywords: metabolic syndrome; green tea; epigallocatechin gallate; EGCG; endothelial dysfunction; cardiovascular diseases metabolic syndrome; green tea; epigallocatechin gallate; EGCG; endothelial dysfunction; cardiovascular diseases
This is an open access article distributed under the Creative Commons Attribution License which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited. (CC BY 4.0).

Scifeed alert for new publications

Never miss any articles matching your research from any publisher
  • Get alerts for new papers matching your research
  • Find out the new papers from selected authors
  • Updated daily for 49'000+ journals and 6000+ publishers
  • Define your Scifeed now

SciFeed Share & Cite This Article

MDPI and ACS Style

Legeay, S.; Rodier, M.; Fillon, L.; Faure, S.; Clere, N. Epigallocatechin Gallate: A Review of Its Beneficial Properties to Prevent Metabolic Syndrome. Nutrients 2015, 7, 5443-5468.

Show more citation formats Show less citations formats

Related Articles

Article Metrics

Article Access Statistics

1

Comments

[Return to top]
Nutrients EISSN 2072-6643 Published by MDPI AG, Basel, Switzerland RSS E-Mail Table of Contents Alert
Back to Top